“Kenya on Monday became the first African country to introduce a routine vaccine against pneumococcal disease, which claims the lives of more than half a million children under five each year,” Deutsche Presse Agentur/The Hindu reports. The GAVI Alliance, which is supporting the vaccine’s roll out, “is aiming to introduce the vaccine to 19 developing countries – including Nicaragua, Guyana, Yemen and Sierra Leone – within a year and hopes to reach more than 40 nations by 2015, depending on funding.”
Access to Health Services
On Monday, the same day the GAVI Alliance helped oversee the roll out of a routine pneumococcal vaccine in Kenya, GAVI chairman Dagfinn Hoybraten highlighted the need for greater reductions in vaccine prices in developing countries during an interview with Reuters, the news service reports. The piece examines the funding mechanism in place to finance the pneumococcal vaccines, known as Advance Market Commitment (AMC), as well as the budget shortfall facing the group (Kelland, 2/14).
Also In Global Health News: Gates Foundation Global Health Head To Step Down; Drug, Medical Supply Shortages In Gaza; Food Security In N. Korea
Gates Global Health Program President To Step Down In June Tachi Yamada, president of the global health program at the Bill & Melinda Gates Foundation, on Monday announced he would step down in June after five years serving in the position, the Associated Press/Seattle Post-Intelligencer reports (2/14). “During his tenure,…
U.N.-Backed Meeting In Bangkok Will Examine How Legal Barriers In Asia Hamper Fight Against HIV/AIDS
“Legal barriers are obstructing the fight against HIV/AIDS in the Asia, where 19 nations outlaw same-sex relations and 29 countries criminalize prostitution, United Nations experts said Wednesday,” on the eve of the Global Commission of HIV and the Law meeting in Bangkok, Deutsche Presse-Agentur/M&C reports (2/16).
Also In Global Health News: Tanzania, MDGs; Malnutrition In Guatemala; Energy-Efficient Cookstoves; Health Issues Facing Refugees From Ivory Coast; China’s Pollution Problem
Tanzania Unlikely To Reach MDG Targets, Local Organizations Say “Local organizations say that it’s unlikely for Tanzania to achieve targets set under the U.N.’s Millennium Development Goals (MDGs) by 2015 because the country is still besieged by pervasive unemployment, high levels of poverty, escalating child mortality and counterproductive rural-urban migration,”…
TIME reports on an oral cholera vaccination program to kick off on Thursday in Bangladesh that researchers hope will determine how good of a “weapon” the mass vaccination strategy can be “against an old disease” (Marshall, 2/15).
Also In Global Health News: Methadone Maintenance In Africa; Dengue Vaccine; HIV/AIDS In Ukraine; Human Rights In Russia; Chevron, USAID $50M MOU
First Methadone Maintenance Program In Sub-Saharan Africa Opens Its Doors In Tanzania The New York Times examines “the first methadone maintenance program in sub-Saharan Africa,” which opened this month in a hospital in Dar es Salaam, Tanzania, with funding support from PEPFAR. “While heroin use is not common in Africa,…
Also In Global Health News: Integrating HIV, Maternal/Child Health; Food Shortages In N. Korea; Climate ‘Vulnerability Index’; Premature Infants In Bangladesh; Sanitation In Niger; Cholera In Ghana
IRIN/PlusNews Examines Efforts To Integrate HIV/AIDS Treatment And Maternal, Child Health Care IRIN/PlusNews examines Kenya’s efforts to integrate maternal and child health care and HIV/AIDS services as a way to ensure more pregnant women and mothers living with HIV/AIDS receive the treatment they need. The article describes the success of…
Star-Ledger Examines Tibotec’s Agreement With Generic Drug Makers On Experimental HIV/AIDS Treatment
In a piece on the move by drug manufacturer Tibotec Pharmaceuticals to grant licenses to generic manufacturers in India and South Africa to create copies of its experimental HIV/AIDS drug, the New Jersey Star-Ledger examines why drug companies are particularly focused on expanding their reach in sub-Saharan Africa.
Inter Press Service Explores How Kenya’s Anti-Counterfeit Act, Possible EU-India Free Trade Agreement Could Scale Back Access To Affordable Medications
Inter Press Service examines how legislation in Kenya targeting counterfeit medications and a possible EU-India Free Trade Agreement could scale back access to affordable and safe generic medications widely used in developing countries. The article describes the toll of counterfeit medicines in Kenya and the decision in 2008 to pass the country’s Anti-Counterfeit Act â€“ a move Onyango Opiyo, the executive director of the Nairobi Network of Post-Test Clubs, which supports people living with HIV/AIDS, says has held up legitimate generic medications. The piece also notes Opiyo’s growing concern over the impact negotiations between the EU and India could have in further slowing access to generic medicines.